Primary follicular lymphoma of the testis in childhood

Cancer

Volumn 85, Issue 7, 1999, Pages 1626-1635

  Finn, Laura S ^a,f   Viswanatha, David S ^b,e   Belasco, Jean B ^a   Snyder, Howard ^a   Huebner, David ^c   Sorbara, Lynn ^d   Raffeld, Mark ^d   Jaffe, Elaine S ^d   Salhany, Kevin E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c KAISER PERMANENTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

^f SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Bcl 2; Bcl 6; Follicular lymphoma; P53; Pediatric lymphoma; Testicular lymphoma; Testicular neoplasm

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; IMMUNOGLOBULIN HEAVY CHAIN; MESNA; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; PROTEIN BCL 2; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; CHILDHOOD CANCER; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; ORCHIECTOMY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTHERN BLOTTING; TESTIS TUMOR;

CHILD; CHILD, PRESCHOOL; GENE REARRANGEMENT; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; TESTICULAR NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033120821     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990401)85:7<1626::AID-CNCR27>3.0.CO;2-0     Document Type: Article

References (51)

1. Brosman SA. Testicular tumors in prepubertal children. Urology 1979;13:581-8.
2. Kay R. Prepubertal testicular tumor registry. J Urol 1993;150: 671-4.
3. Doll DC, Weiss RB. Malignant lymphoma of the testis. Am J Med 198681:515-24.
4. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-60.
5. Bruce J, Gough DCS. Long-term follow-up of children with testicular tumors: surgical issues. Br J Urol 1991;67:429-33.
6. Turley HK, Moore TD. Malignant lymphoma primary manifested as a testicular tumor. J Urol 1952;68:744-6.
7. Weitzner S, Gropp A. Primary reticulum cell sarcoma of testis in a 12-year-old. Cancer 1976;37:935-8.
8. Rao SP, Miller ST, Menell J, Glassberg KI. Localized non-Hodgkin's lymphoma of the testis in a child. Am J Pediatr Hematol Oncol 1993;15:443.
9. Moertel CL, Watterson J, McCormick SR, Simonton SC. Follicular large cell lymphoma of the testis in a child. Cancer 1995;75:1182-6.
10. Warnke RA, Weiss LM, Chan JKC, Cleary ML, Dorfman RF. Malignant lymphoma, follicular (small cleaved, mixed, and large cell; centroblastic-centrocytic and centroblastic). In: Atlas of tumor pathology. Tumors of the lymph nodes and spleen. Fascicle 14, Third series. Washington, DC: Armed Forces Institute of Pathology, 1995:63-118.
11. Hutter JJ, Favara BE, Nelson M, Holton CP. Non-Hodgkin's lymphoma in children: correlation of CNS disease with initial presentation. Cancer 1975;36:2132-7.
12. Hausner RJ, Rosas-Uribe A, Wickstrum DA, Smith PC. Non-Hodgkin's lymphoma in the first two decades of life: a pathological study of 30 cases. Cancer 1977;40:1533-47.
13. Cebrian-Bonesana A, Schvartzman E, Roca-Garcia C, Pependieck C, Sackmann-Muriel F, Ojeda FG, et al. Non-Hodgkin's lymphoma in children: an analysis of 122 cases from Argentina. Cancer 1978;41:2372-8.
14. Glatstein E, Kim H, Donaldson SS, Dorfman RF, Gribbler TJ, Wilbur JR, et al. Non-Hodgkin's lymphomas. VI. Results of treatment in children. Cancer 1974;34:204-11.
15. Murphy SB, Frizzera G, Evans AE. A study of childhood non-Hodgkin's lymphoma. Cancer 1975;36:2121-31.
16. Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin's lymphoma of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol 1989;7:186-93.
17. Yunis JJ, Oken MM, Kaplan ME, Ensrud KM, Howe RR, Theologides A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 1982;307:1231-6.
18. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M. Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. Af Engl J Med 1987; 316:79-84.
19. Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, et al. p53 mutation is associated with progression of follicular lymphomas. Blood 1993;82:1994-2004.
20. LoCoco F, Gaidano G, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993;82:2289-95.
21. LoCoco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, et al. Rearrangements of the BCL-6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 1994;83:1757-9.
22. Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezzella F, et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 1994; 83:2423-7.
23. Otsuki T, Yano T, Clark HM, Bastard C, Kerckaert JP, Jaffe ES, et al. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood 1995;85:2877-84.
24. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of working formulation for clinical usage. Cancer 1982;49:2112-35.
25. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
26. Chhanabhai M, Adomat SA, Gascoyne RD, Horsman DE. Clinical utility of heteroduplex analysis of TCR gamma gene rearrangements in the diagnosis of T-cell lymphoproliferative disorders. Am J Clin Pathol 1997;108:295-301.
27. Horsman DE, Gascoyne RD, Coupland RW, Coldman AJ, Adomat SA. Comparison of cytogenetic analysis, Southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma. Am J Clin Pathol 1995;103: 472-8.
28. Ye BH, Lista F, LoCoco F, Knowles DM, Offit K, Chaganti RSK, et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993;262:747-50.
29. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971;31:1860-1.
30. Kellie SJ, Pui C-H, Murphy SB. Childhood non-Hodgkin's lymphoma involving the testis: clinical features and treatment outcome. J Clin Oncol 1989;7:1066-70.
31. Ferry JA, Harris NL, Young RH, Coen J, Zietman A, Scully RE. Malignant lymphoma of the testis, epididymis, and spermatic cord. Am J Surg Pathol 1994;18:376-90.
32. Frizzera G, Murphy SB. Follicular (nodular) lymphoma in childhood: a rare clinical-pathological entity. Cancer 1979; 44:2218-35.
33. Winberg CD, Nathwani BN, Bearman RM, Rappaport H. Follicular (nodular) lymphoma during the first two decades of life: a clinicopathologic study of 12 patients. Cancer 1981; 48:2223-35.
34. Pinto A, Hutchison RE, Grant LH, Trevenen CL, Berard CW. Follicular lymphomas in pediatric patients. Mod Pathol 1990;3:308-13.
35. Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med 1988; 318:1638-44.
36. Zutter M, Hockenbery D, Silverman GA, Korsmeyer SJ. Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood 1991; 78:1062-68.
37. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-86.
38. Nguyen PL, Zukerberg LR, Benedict WF, Harris NL. Immunohistochemical detection of p53, bcl-2 and retinoblastoma proteins in follicular lymphoma. Am J Clin Pathol 1996;105:538-43.
39. Feinstein E, Cimino G, Gale RP, Alimena G, Berthier R, Kishi K, et al. p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci U S A;1991;88:6293-7.
40. Baron BW, Nucifora G, McCabe N, Espinosa R III, Le Beau MM, McKeithan TW. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27; q32) and t(3;22)(q27;q11) in B cell lymphomas. Proc Natl Acad Sci U S A 1993;90:5262-6.
41. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 1993;5:66-70.
42. Michaud GY, Gascoyne RD, McNeil BK, Anderson ME, Horsman DE. Bcl-6 and lymphoproliferative disorders. Leuk Lymphoma 1997;26:515-25.
43. Migliazza A, Martinotti S, Chen W, Fusco C, Ye BH, Knowles DM, et al. Frequent somatic hypermutation of the 5′ non-coding region of the Bcl-6 gene in B cell lymphoma. Proc Natl Acad Sci USA 1995;92:12520-4.
44. Cattoretti G, Chang C-C, Cechova K, Zhang J, Ye BH, Falini B, et al. BCL-6 protein is expressed in germinal-center B cells. Blood 1995;86:45-53.
45. Onizuka T, Moriyama M, Yamochi T, Kuroda T, Kazama A, Kanazawa N, et al. BCL-6 protein product, a 92-to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 1995; 86:28-37.
46. Flenghi L, Bigerna B, Fizzotti M, Venturi S, Pasqualucci L, Pileri S, et al. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formolresistant epitope on the human Bcl-6 protein amino-terminal region. Am J Pathol 1996;148:1543-55.
47. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. Control of inflammation, cytokine expression and germinal center for-mation by Bcl-6. Science 1997;276:589-92.
48. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997;16: 161-70.
49. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998;280:1750-2.
50. Offit K, Lo Coco F, Louie DC, Parsa NZ, Leung D, Portlock C, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 1994; 331:74-80.
51. E non-Hodgkin's lymphoma of the testis. J Urol 1996; 155:943-6.